CN Patent

CN108148840B — 用于治疗补体-相关失调的适体治疗

Assigned to Archemix LLC · Expires 2021-09-24 · 5y expired

What this patent protects

本发明提供了核酸治疗及在补体‑相关失调的治疗中使用这些核酸治疗的方法。

USPTO Abstract

本发明提供了核酸治疗及在补体‑相关失调的治疗中使用这些核酸治疗的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108148840B
Jurisdiction
CN
Classification
—
Expires
2021-09-24
Drug substance claim
No
Drug product claim
No
Assignee
Archemix LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.